Cantel Medical (CMN) Cash Flow Statement

Click line-items for a historical chart and %

Net income	18.8M
Depreciation	3.45M
Amortization	3.91M
Stock-based compensation expense	2.92M
Amortization of debt issuance costs	100K
Loss (gain) on disposal of fixed assets	224K
Impairment of convertible notes receivable
Deferred income taxes
Excess tax benefits from stock-based compensation	0
Accounts receivable	1.58M
Inventories	-1.82M
Prepaid expenses and other current assets	-2.8M
Accounts payable and other current liabilities	-5.29M
Income taxes payable
Net cash provided by operating activities	24.91M
Capital expenditures	-8.14M
Proceeds from disposal of fixed assets	21K
Acquisition of Gambro Water	-57.77M
Acquisition of Confirm
Acquisition of the Byrne Medical Business
Other, net	255K
Net cash used in investing activities	-65.64M
Borrowings under term loan facility, net of debt issuance costs
Borrowings under revolving credit facility, net of debt issuance costs	61M
Repayments under term loan facility
Repayments under revolving credit facility	-16M
Proceeds from exercises of stock options
Dividends paid
Excess tax benefits from stock-based compensation	0
Purchases of treasury stock	-6.22M
Net cash provided by financing activities	38.78M
Effect of exchange rate changes on cash and cash equivalents	-289K
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period	28.37M
Cash and cash equivalents at end of period	26.14M

Entities mentioned with CMN

View All Entities